Downregulation of miR-892b inhibits the progression of osteoarthritis via targeting Cyclin D1 and Cyclin D2

CONCLUSION: MiR-892b antagomir inhibits the progression of OA via targeting Cyclin D1 and Cyclin D2. Thus, our finding might supply a novel target for OA treatment.PMID:34102226 | DOI:10.1016/j.yexcr.2021.112683

Source: Experimental Cell Research - June 8, 2021 Category: Cytology Authors: Jiajun Zhao Zhen Zhang Tantan Zuo Jie Yu Shihao Yang Yitao Yang Xinqi Li Jia Zheng Source Type: research